A 4-week Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects With Knee Osteoarthritis

Summary

A 4-week, Randomized, Double-blind, Multicenter, Placebo-controlled Phase 2 Study to Evaluate the Efficacy and Safety of HP-5000 in Subjects with Osteoarthritis (OA) of the Knee

Timeline

Start

2017-09-07

Primary completion

2019-09-25

Completion

2019-09-25

Outcome

Results reported · no primary-endpoint met/missed verdict (typical of a dose-finding / safety study)

registry analysis (superiority test); Diclofenac Sodium Active Topical Patch 1 vs Placebo Patch; p = 0.0110; Lest-Squared Mean Differences 0.0110; Mixed Models Analysis NCT03277066 ↗

Drugs

Indications